Related Experiment Video
Updated: Jun 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Atherosclerosis in CKD: differences from the general population
Tilman B Drüeke1, Ziad A Massy
1Inserm ERI-12, UFR de Médecine et de Pharmacie, Université de Picardie Jules Verne, 80037 Amiens, France. tilman.drueke@inserm.fr
Insights
Cardiovascular disease is more common in chronic kidney disease (CKD) patients. Atherosclerosis is aggravated by CKD, increasing the fatality of cardiovascular events.
Area of Science:
- Nephrology
- Cardiology
- Pathophysiology
Background:
- Cardiovascular morbidity and mortality are significantly higher in patients with chronic kidney disease (CKD), particularly end-stage renal disease.
- The precise role of atherosclerosis in CKD-related cardiovascular disease has been debated, with early theories emphasizing its primary role and accelerated progression due to uremia.
- More recent research suggests other mechanisms like arteriosclerosis, vascular calcification, and cardiac myocyte issues are also involved.
Purpose of the Study:
- To clarify the contribution of atherosclerosis to cardiovascular disease in patients with chronic kidney disease (CKD).
- To elucidate the interplay between CKD, aging, and the development and progression of cardiovascular abnormalities.
Main Methods:
- Review of clinical and experimental findings.
- Analysis of imaging and morphological studies related to cardiovascular disease in CKD.
- Hypothesis formulation based on existing evidence.
Main Results:
- Initial cardiovascular abnormalities in CKD include arteriosclerosis, left ventricular diastolic dysfunction, and hypertrophy.
- Atherosclerosis prevalence increases with age and is aggravated, but not solely induced, by CKD.
- Cardiovascular events linked to atherosclerosis are more frequently fatal in CKD patients.
Conclusions:
- CKD aggravates atherosclerosis, contributing to increased cardiovascular event fatality.
- Arteriosclerosis and ventricular dysfunction are key early cardiovascular changes in CKD.
- Understanding these mechanisms is crucial for managing cardiovascular risk in CKD patients.
Abstract:
The prevalence of cardiovascular morbidity and mortality is higher in patients with chronic kidney disease (CKD)-especially those with end-stage renal disease-than in the general population. The contribution of atherosclerosis to cardiovascular disease in patients with CKD remains unclear. Researchers in the 1970s proposed that atherosclerosis was the main cause of cardiovascular disease in patients with CKD and that its progression, based on observations of patients on long-term dialysis, was accelerated by the uremic state. Subsequent reports, however, favor the involvement of other mechanisms, such as arteriosclerosis (characterized by vascular stiffening), vascular calcification, 'myocyte/capillary mismatch', congestive cardiomyopathy, and sudden cardiac death. Imaging and morphological studies have contributed to our understanding of the pathogenesis and progression of cardiovascular disease associated with CKD. Based on clinical and experimental findings, we hypothesize the following: the initial cardiovascular abnormalities in the CKD setting include arteriosclerosis, left ventricular diastolic dysfunction, and left ventricular hypertrophy, abnormalities which, in adult patients, are often accompanied by atherosclerosis. The prevalence of atherosclerosis increases with age and is aggravated, but not specifically induced, by CKD. The cardiovascular events associated with atherosclerosis are more often fatal in patients with CKD than in individuals without CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care

